KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Raw Materials: 2012-2021

Historic Raw Materials for TherapeuticsMD (TXMD) over the last 9 years, with Dec 2021 value amounting to $3.0 million.

  • TherapeuticsMD's Raw Materials fell 44.19% to $1.9 million in Q3 2022 from the same period last year, while for Sep 2022 it was $1.9 million, marking a year-over-year decrease of 44.19%. This contributed to the annual value of $3.0 million for FY2021, which is 18.84% down from last year.
  • According to the latest figures from FY2021, TherapeuticsMD's Raw Materials is $3.0 million, which was down 18.84% from $3.7 million recorded in FY2020.
  • TherapeuticsMD's Raw Materials' 5-year high stood at $5.7 million during FY2019, with a 5-year trough of $19,400 in FY2018.
  • Over the past 3 years, TherapeuticsMD's median Raw Materials value was $3.7 million (recorded in 2020), while the average stood at $4.2 million.
  • Its Raw Materials has fluctuated over the past 5 years, first soared by 29,290.45% in 2019, then tumbled by 34.27% in 2020.
  • Over the past 4 years, TherapeuticsMD's Raw Materials (Yearly) stood at $19,400 in 2018, then skyrocketed by 29,290.45% to $5.7 million in 2019, then slumped by 34.27% to $3.7 million in 2020, then declined by 18.84% to $3.0 million in 2021.